Boone C - Search Results

1

Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.

Sneige N, Lagios MD, Schwarting R, Colburn W, Atkinson E, Weber D, Sahin A, Kemp B, Hoque A, Risin S, Sabichi A, Boone C, Dhingra K, Kelloff G, Lippman S. Sneige N, et al. Among authors: boone c. Hum Pathol. 1999 Mar;30(3):257-62. doi: 10.1016/s0046-8177(99)90002-3. Hum Pathol. 1999. PMID: 10088542

2

Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.

Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN. Hoque A, et al. Among authors: boone cw. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):249-59. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303595

3

Biomarker end-points in cancer chemoprevention trials.

Boone CW, Kelloff GJ. Boone CW, et al. IARC Sci Publ. 1997;(142):273-80. IARC Sci Publ. 1997. PMID: 9354926 Review.

4

Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.

Boone CW, Kelloff GJ. Boone CW, et al. Cancer Surv. 1998;32:133-47. Cancer Surv. 1998. PMID: 10489626 Review.

5

The natural history of intraepithelial neoplasia: relevance to the search for intermediate endpoint biomarkers.

Boone CW, Kelloff GJ, Steele VE. Boone CW, et al. J Cell Biochem Suppl. 1992;16G:23-6. doi: 10.1002/jcb.240501104. J Cell Biochem Suppl. 1992. PMID: 1469901 Review.

6

Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention.

Boone CW, Kelloff GJ. Boone CW, et al. J Cell Biochem Suppl. 1993;17F:37-48. doi: 10.1002/jcb.240531007. J Cell Biochem Suppl. 1993. PMID: 8412208 Review.

7

Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials.

Bacus JW, Boone CW, Bacus JV, Follen M, Kelloff GJ, Kagan V, Lippman SM. Bacus JW, et al. Among authors: boone cw. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1087-94. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10613341

8

Endpoint markers for cancer chemoprevention trials derived from the lesion of precancer (intraepithelial neoplasia) measured by computer-assisted quantitative image analysis.

Boone CW, Kelloff GJ. Boone CW, et al. J Cell Biochem Suppl. 2000;34:67-72. doi: 10.1002/(sici)1097-4644(2000)77:34+<67::aid-jcb12>3.0.co;2-j. J Cell Biochem Suppl. 2000. PMID: 10762017 Review.

9

Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia.

Boone CW, Kelloff GJ. Boone CW, et al. J Cell Biochem Suppl. 1994;19:10-22. J Cell Biochem Suppl. 1994. PMID: 7823580 Review.

10

Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.

Boone CW, Kelloff GJ, Steele VE. Boone CW, et al. Cancer Res. 1992 Apr 1;52(7):1651-9. Cancer Res. 1992. PMID: 1551096 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

785 results

Search Page

Filters